Issue divides Bush advisers

By M. Asif Ismail

WASHINGTON, August 30, 2001 — Within the Bush administration, two senior aides, chief strategist Karl Rove and Health and Human Services Sec

Excerpts from this story referencing "chief lobbyist":

"… e industry benefiting from stem cell research are Nicholas Calio, Bush’s chief lobbyist on Capitol Hill, and his deputy, Kristen Chadwick. Calio’s former lobbyi …"

Capitol Hill stem-cell backers received health industry dollars

By M. Asif Ismail and Christine Morente

WASHINGTON, August 30, 2001 — U.S. representatives and senators who strongly pushed for federally subsidized embryonic stem cell research ha

Globalizing research

By Alexander Cohen

Across Asia, biotechnology sector thrives
Advertisement

Where scientists call the shots

By Tamra Traubmann

Advanced capabilities and lax regulation put Israel on the leading edge of cloning

Closing in on human cloning

By M. Asif Ismail and Agustín Armendariz

The federal government is funding research in primate cloning technology. Why?

Regulating cloning

By M. Asif Ismail

The biotech industry pushes its agenda in the states
Advertisement

Lobbying, old-time politics block legislation on human cloning

By M. Asif Ismail

Bush administration articulates no position

Embryo research: profit vs ethics?

By Shaun Taylor-Corbett

Corporations team up with patients' rights groups to overpower opposition to research that destroys embryos, but could save lives